Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06384053 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Skin Cancer and Hyperthermia and Radiotherapy

Study acronym: SAHARA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 15, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2024 to Jan 1, 2025
    • Study sites: 2 to 4
    • Collaborators: 1 to 3
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The SAHARA trial assesses wether combining ultrahypofractionated accelerated radiotherapy (RT) with hyperthermia is as effective as standard hypofractionated high-dose radiation in treating non-melanoma skin cancer (NMSC).
Trial Details
NCT Number NCT06384053
Lead Sponsor Kantonsspital Winterthur KSW
Collaborators: Luzerner Kantonsspital, Lindenhofgruppe AG, Kantonsspital Aarau
Conditions
(from sponsor)		 Basal Cell Carcinoma, Squamous Cell Carcinoma Skin, Non-melanoma Skin Cancer
Related terms Basal Cell Carcinoma, Hyperthermia
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov